Foghorn Return On Equity from 2010 to 2024
| FHTX Stock | USD 6.20 0.52 9.15% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 1.27511336 | Current Value 1.34 | Quarterly Volatility 251.13440234 |
Check Foghorn Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Foghorn Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 11.1 M, Interest Income of 11.1 M or Depreciation And Amortization of 9.1 M, as well as many indicators such as Price To Sales Ratio of 7.53, Dividend Yield of 0.0 or Days Sales Outstanding of 66.4 K. Foghorn financial statements analysis is a perfect complement when working with Foghorn Therapeutics Valuation or Volatility modules.
Foghorn | Return On Equity |
Latest Foghorn Therapeutics' Return On Equity Growth Pattern
Below is the plot of the Return On Equity of Foghorn Therapeutics over the last few years. Return on Equity is the amount of Foghorn Therapeutics net income returned as a percentage of Foghorn Therapeutics equity. Return on equity measures Foghorn Therapeutics profitability by revealing how much profit Foghorn Therapeutics generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Foghorn Therapeutics' Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Foghorn Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -4.7 | 10 Years Trend |
|
Return On Equity |
| Timeline |
Foghorn Return On Equity Regression Statistics
| Arithmetic Mean | (64.29) | |
| Coefficient Of Variation | (390.61) | |
| Mean Deviation | 121.04 | |
| Median | 0.67 | |
| Standard Deviation | 251.13 | |
| Sample Variance | 63,068 | |
| Range | 973 | |
| R-Value | (0.31) | |
| Mean Square Error | 61,415 | |
| R-Squared | 0.1 | |
| Significance | 0.26 | |
| Slope | (17.38) | |
| Total Sum of Squares | 882,959 |
Foghorn Return On Equity History
About Foghorn Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Foghorn Therapeutics income statement, its balance sheet, and the statement of cash flows. Foghorn Therapeutics investors use historical funamental indicators, such as Foghorn Therapeutics's Return On Equity, to determine how well the company is positioned to perform in the future. Although Foghorn Therapeutics investors may use each financial statement separately, they are all related. The changes in Foghorn Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Foghorn Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Foghorn Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Foghorn Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Equity | 1.28 | 1.34 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Foghorn Stock Analysis
When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.